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Regulation of Lipid Biosynthesis, Sliding Motility, and Biofilm
Formation by a Membrane-Anchored Nucleoid-Associated Protein of
Mycobacterium tuberculosis
Soumitra Ghosh,a Shantinath S. Indi,a Valakunja Nagarajaa,b
Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, Indiaa; Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, Indiab
Bacteria use a number of small basic proteins for organization and compaction of their genomes. By their interaction with DNA,
these nucleoid-associated proteins (NAPs) also influence gene expression. Rv3852, a NAP ofMycobacterium tuberculosis, is con-
served among the pathogenic and slow-growing species of mycobacteria. Here, we show that the protein predominantly localizes
in the cell membrane and that the carboxy-terminal region with the propensity to form a transmembrane helix is necessary for
its membrane localization. The protein is involved in genome organization, and its ectopic expression inMycobacterium smeg-
matis resulted in altered nucleoid morphology, defects in biofilm formation, sliding motility, and change in apolar lipid profile.
We demonstrate its crucial role in regulating the expression of KasA, KasB, and GroEL1 proteins, which are in turn involved in
controlling the surface phenotypes in mycobacteria.
Tuberculosis is a major infectious disease with an ever-expand-ing global importance. Current estimates indicate that about
one-third of the human population is latently infected with My-
cobacterium tuberculosis, and an estimated 2.5 million people die
of tuberculosis annually (1). M. tuberculosis is one of the most
successful human pathogens, well adapted to long-term residence
inside the host macrophages. The secret of M. tuberculosis as a
successful pathogen can be ascribed to its extraordinary stealth
and ability to adapt within the host cell during the course of infec-
tion (2). Genes that are involved in the adaptation to environmen-
tal changes and intracellular survival are controlled by specific
transcription factors, as well as by global regulators, such as the
nucleoid-associated proteins (NAPs) (3, 4).
NAPs, also referred to as histone-like proteins, are low-molec-
ular-weight, basic proteins primarily responsible for the compac-
tion of the bacterial genome. Apart from their role in the organi-
zation and condensation of the bacterial chromosome, they
influence different DNA transaction processes, viz., replication,
regulation of gene expression, and recombination (5). H-NS is
one of the abundant NAPs in the Enterobacteriaceae and has been
well characterized from Escherichia coli and Salmonella enterica
serovar Typhimurium (4). In these organisms,H-NS regulates the
expression of a large number of genes by cooperative binding to
high-affinity sites in the vicinity of the promoters (6, 7). In accor-
dance with its global regulatory role in E. coli and Salmonella,
mutations in hns are highly pleiotropic. H-NS homologues from
otherGram-negative bacteria share a high degree of sequence sim-
ilarity with the E. coli protein (8). Lsr2, a functional homologue of
H-NS with remote sequence conservation (Fig. 1A), has been
identified in various actinomycetes (9). The M. tuberculosis Lsr2
protein exhibits H-NS-like DNA binding properties and has also
been shown to complement E. coliH-NS knockout (KO) cells (9,
10). Lsr2 regulates various cellular processes, including antibiotic
resistance, biofilm formation, and cell wall biosynthesis (11–13),
in mycobacteria, thus exhibiting pleiotropic effects similar to
those of H-NS.
Although M. tuberculosis seems to have an underrepresenta-
tion ofNAPs compared toE. coli (14), one of theNAPs, Rv3852, in
the genome sequence was annotated as a possible H-NS (15). No-
tably, E. coli H-NS showed only 10% sequence similarity to
Rv3852 (Fig. 1A). Thus, neither Lsr2 nor Rv3852 shows significant
sequence similarity to the canonical H-NS, although functionally
Lsr2 resembled it in many respects (9, 10). These differences war-
ranted a thorough investigation of the properties of Rv3852.Here,
we demonstrate that the properties of Rv3852 are markedly dif-
ferent from those of H-NS. The carboxy-terminal (C-terminal)
region of the protein contains a transmembrane helix that anchors
the protein to the cell membrane. Its expression in M. smegmatis
resulted in pleiotropic phenotypic changes. In addition to the
change in nucleoid structure, the alterations include compro-
mised ability of the bacterium to form biofilm, reduction in slid-
ing motility, and altered colony morphology and lipid profile.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. Mycobacterium smeg-
matis mc2155 cells were grown in Middlebrook 7H9 broth or 7H9 agar.
The E. coliK-12 strainMC4100was used as thewild-type strain. PD32, the
hns knockout strain of MC4100 (E. coli K-12 MC4100 hns-260::Apr), and
PD32/pAF201 (strain PD32 complemented with E. coli hns) were kind
gifts from C. J. Dorman (Trinity College, Dublin, Ireland). To analyze
biofilm formation, M63minimal medium supplemented with 0.2% glyc-
erol, 0.5% Bacto-Casitone (BD), 1 mM MgSO4, and 0.7 mM CaCl2 was
used. Antibiotics were added at the following concentrations: ampicillin,
100 g/ml; kanamycin, 25 g/ml; and chloramphenicol, 25 g/ml.
Sequence alignment and analysis. Sequence searches of the nonre-
dundant (nr) database were carried out with the BLASTP program (http:
//www.ncbi.nlm.nih.gov), using the sequence of Rv3852 as a query. Mul-
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tiple-sequence alignment was carried out using ClustalW2 and edited
with the Genedoc software. The transmembrane helix prediction was
carried out using the TMHMM Server, v. 2.0 (http://www.cbs.dtu.dk).
-Helical regions were identified with the secondary-structure prediction
program TMpred. (http://www.ch.embnet.org/software/TMPRED_form
.html). The helical-wheel arrangement of the transmembrane region of
Rv3852 was derived from http://cti.itc.virginia.edu/~cmg/Demo/wheel
/wheelApp.html.
Cloning, expression, and purification of Rv3852. The Rv3852 gene
(GenBank CAB06214.1) was PCR amplified fromM. tuberculosis H37Rv
genomic DNA using the forward primer 5=-ATGGATCCATGCATCATC
ATCATCATCACGCAGACCCGCAGG-3=, containing the six histidine
codons, and the reverse primer 5=-GCTCTAGATCAGCGGCGGCGCA
G-3=. The PCR amplicon was cloned into the BamHI and XbaI sites of
expression vectors pJAM2 (16) and pBAD33 to generate pJ-Rv3852
and pB-Rv3852, respectively. The C-terminal deletion construct (pJ-
Rv3852CTD) was created by introducing a stop codon after 330 nucle-
otides. Plasmid pJ-Rv3852or pJ-Rv3852CTDwas electroporated intoM.
smegmatis, and pB-Rv3852 was used to transform the E. coli PD32 strain.
TheM. smegmatis transformants were grown onMiddlebrook 7H9 broth.
The recombinant protein was expressed by inducing the cells with 2%
acetamide for 8 h at 37°C. Cells were harvested; resuspended in buffer
containing 10 mM Tris-HCl, pH 8.0, 100 mMKCl, 5 mM imidazole; and
lysed using a French press. The lysate was centrifuged at 13,000 rpm for 20
min at 4°C. The pellet was subjected to extraction in the presence of 0.5%
Triton X-100 and 800 mM KCl. The supernatant was mixed with Ni-
nitrilotriacetic acid metal affinity chromatography matrix (Qiagen) and
purified according to the manufacturer’s instructions. The protein-con-
taining fractions were pooled and dialyzed against buffer B (10 mM Tris-
HCl, 100mMKCl, and 1mMEDTA), applied to an SP Sepharose HiTrap
column, and eluted with 0.1 to 1 M linear KCl gradient.
Glucoside fermentation assay. An aryl--D-glucoside fermentation
assay was carried out in MacConkey agar (Difco) supplemented with
0.5% salicin. E. coli strains were streaked on the plates and incubated at
37°C for 18 h. MacConkey agar is an indicator medium used to differen-
tiate Gram-negative bacteria on the basis of their sugar utilization abili-
ties. Those bacteria that ferment the given sugar produce acidic by-prod-
ucts, causing a drop in pHand giving rise to pink colonies, while the others
that fail to ferment the sugar grow using the peptone and produce ammo-
nia, leading to an increase in pH, resulting in yellow/white colonies.
Electrophoretic mobility shift assays (EMSA). End-labeled 30-bp
double-stranded DNA (5=CCAACTTCCCTAACCCAGCTGCGATCCG
TT3=) (1 nM)was incubated with increasing concentrations of protein on
ice for 20 min in the binding buffer (10 mMHEPES, pH 7.4, and 50 mM
KCl) in a 20-l reaction volume. DNA-protein complexes were electro-
phoresed on 7% (wt/vol) polyacrylamide gels (39:1 acrylamide-bisacryl-
amide) in TBE (45mMTris-borate, pH 8.3, 1mMEDTA) at 100 V in 4°C
for 2.5 h. The DNA-protein complexes were visualized by phosphorim-
aging.
Topoisomerase assays.TheM. smegmatisDNAgyrase and topoisom-
erase I (TopoI) were purified as described previously (17, 18). For super-
coiling, 400 ng of relaxed circular pUC18 DNA was incubated with
Rv3852 in a buffer (35 nM Tris-HCl, pH 7.5, 5 mM MgCl2, 25 mM po-
tassium glutamate, 2 mM spermidine, 1.4 mM ATP, 50 g/ml bovine
FIG 1 Rv3852 does not complement the E. coli hns knockout strain. (A) Sequence alignment of E. coli H-NS, M. tuberculosis Rv3852, and Lsr2 proteins. The
shaded regions denote the sequence conservation, and the letters below indicate the identical amino acids. Every 10th residue in the sequence is marked either by
asterisks or by the exact number. (B) The mucoidy phenotype of the hns KO strain was complemented by E. coli hns, but not by Rv3852. (C) Fermentation of
salicin on a MacConkey agar plate indicated that Rv3852 fails to complement E. coliH-NS.
Ghosh et al.
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serum albumin [BSA], 90 g/ml yeast tRNA, and 5% glycerol) and M.
smegmatis DNA gyrase at 37°C for 30 min. After heat inactivation of the
assay mixture at 68°C and Proteinase K treatment (5 g/20-l reaction
mixture) at 37°C for 15 min, the products were resolved on a 1% agarose
gel. To monitor the DNA relaxation, negatively supercoiled pUC18 DNA
(400 ng) was incubated with Rv3852 (10 to 500 nM) in reaction buffer (40
mM Tris-HCl, pH 8.0, 20 mM NaCl, 5 mMMgCl2, and 1 mM EDTA) at
room temperature for 15 min, followed by the addition of 5 nMM. smeg-
matis TopoI and further incubation at 37°C for 30 min. The reactions
were terminated and analyzed as described above.
Western blot analysis.The cellular level of Rv3852was determined by
semiquantitative Western blotting, as described previously (19). Briefly,
theM. tuberculosisH37Ra cells were grown to an optical density at 600 nm
(OD600) of 0.6, corresponding to themid-log phase (day 5) of growth, and
cells were suspended in lysis buffer and boiled for 45 min. The total cell
lysate was subjected to SDS-PAGE, along with different amounts of puri-
fied Rv3852 (40, 30, 20, and 15 ng), and detected by immunoblotting with
anti-Rv3852 antibody. Quantitation of band intensities was carried out by
scanning the bands and analyzing the image with Image Gauge V2.54
software. The number of molecules per cell was obtained from the total
number of cells used for the preparation of cell lysates. To compare the
levels of Rv3852 expression in different cells, M. tuberculosis, E. coli hns
KO harboring pB-Rv3852, and M. smegmatis cells harboring pJ-Rv3852,
were grown to mid-log phase. Equal amounts of total cell lysate were
resolved on 12% SDS-PAGE, followed by immunoblotting, as described
above. The experiments were repeated three times.
Fluorescence microscopy and transmission electron microscopy.
M. smegmatis cells harboring pJ-Rv3852, pJ-Rv3852CTD, or pJAM2vec-
tor alone (control) were grown inMiddlebrook 7H9 in the presence of 2%
acetamide. Cells were fixed overnight with phosphate-buffered saline
(PBS) containing 1% toluene and 2% Triton X-100 and stained with 0.1
mg/ml 4=-6-diamidino-2-phenylindole (DAPI). The cells were visualized
in a Zeiss Axio Imager fluorescence microscope under a 100 objective.
To analyze the ultrastructure of the cells by transmission electronmicros-
copy, sampleswere prepared following the previously published protocols
(20). In brief, the cells were washed, fixed with 4% paraformaldehyde and
2.5% glutaraldehyde, postfixed with 1% OsO4, dehydrated in a graded
series of acetone, and embedded in Spurr’s resin. Thin sections (70 nM)
were cut using a Reichert Ultracut E microtome, placed on a copper grid,
and stained with 2% uranyl acetate and Reynold’s lead citrate. A JEOL
TEM 1200 EX electron microscope operating at 80 kV was used for
imaging.
Immunoelectron microscopy. The bacteria were first embedded in
agar and fixed in amixture of 4% freshly prepared paraformaldehyde and
0.5% glutaraldehyde in PBS (pH 7.4). The samples were then treated with
0.05 M NH4Cl buffer for 15 min and washed with PBS. The cells were
dehydrated in graded ethanol and embedded in London Resin white. Ul-
trathin sections were mounted on nickel grids and treated with blocking
solution (2% BSA in PBS). The sections were incubated overnight with
affinity-purifiedmouse anti-Rv3852 polyclonal antibody, followed by an-
ti-mouse IgG–gold for 30 min. After five washings, the sections were
poststainedwith 2%uranyl acetate inmethanol, followed by stainingwith
lead citrate.
Subcellular fractionation. Subcellular fractionation was carried out
as described previously (21) withminormodifications.M. smegmatis cells
were resuspended in buffer containing 10 mMTris HCl, pH 7.5, 100 mM
NaCl, and 0.1mMEDTA and lysed by sonication. The lysates were treated
with DNase I and RNase for 30min, and the resulting lysate was subjected
to differential centrifugation as described previously (21). The pellet from
centrifugation at 27,000 gwas resubmitted to lysis and recentrifuged at
1,000  g, and the resulting supernatant was centrifuged at 27,000  g.
The supernatants from the two rounds of centrifugation at 27,000  g
were pooled and centrifuged at 100,000  g. The resulting pellet con-
tained the cell membranes, whereas the supernatant corresponded to the
cytosol. The factions were loaded onto 12% SDS-PAGE, and the presence
of the recombinant proteins was detected by Western blotting with anti-
His antibody.
To determine the distribution of DNA in the membrane fraction,
equal amounts ofM. smegmatis cell pellets were resuspended in lysis buf-
fer (10mMTris-HCl, pH 7.5, 100mMNaCl, and 1mMEDTA) and lysed
by sonication. The lysate was treated with 5 g/ml RNase A for 1 h, and 5
mg of the total protein from the 27,000 g supernatants of the respective
lysates were subjected to fractionation as described above. Themembrane
fractions were solubilized with 8 M urea and diluted in lysis buffer. The
DNA content was estimated by DAPI-based fluorescence assay (22).
Pellicle and biofilm formation assay. Pellicle formation by different
strains was monitored by growing the cultures of M. smegmatis without
shaking at 37°C for 24 h in Middlebrook 7H9 medium devoid of Tween
80. An assay for biofilm formation was carried out as described previously
(12)withminormodifications.M63mediumcontaining 2%acetamide (2
ml) was added to 24-well polyvinyl chloride (PVC) plates and inoculated
with cells to an optical density at 600 nm of 0.03. The plates were incu-
bated at 37°C for 48 h, and free-floating cells were washed with deionized
water, stained with 1% crystal violet, and assayed by spectrophotometric
reading of the ethanol extract at 570 nm.
Colonymorphology analysis and slidingmotility assay.M. smegma-
tis cells transformed with pJAM2, pJ-Rv3852, or pJ-Rv3852CTD were
grown onMiddlebrook 7H9 agar containing 2% acetamide to analyze the
colony morphology. Motility assays were carried out as described previ-
ously (23). Briefly, cells were cultured in 7H9 broth to mid-logarithmic
phase (OD600, 0.8 to 1.0) before 2-l aliquots were spotted onto motility
medium consisting of M63 salts supplemented with 0.5% Casamino Ac-
ids, 0.2% glycerol, 1 mM MgCl2, and 10 M FeCl2 and solidified with
0.3% (wt/vol) agarose. The plates were incubated for 24 h at 37°C under
humidified conditions.
Cell wall lipid analysis. M. smegmatis cells were grown on Middle-
brook 7H9 medium, and equal cell mass (50 mg) was taken from control
and Rv3852- and Rv3852CTD-expressing cells for lipid analysis. Lipid
analysis was carried out using thin-layer chromatography (TLC) on silica
gel 60 F254 plates (Merck). The glycopeptidolipids (GPLs) were isolated
from cells as described previously (23). Deacetylation of lipid extracts was
carried out by alkaline methanolysis. TLC plates were developed in the
solvent mixture, chloroform-methanol-water (90:10:1), after application
of the GPL samples. The GPL spots were visualized by spraying 10%
H2SO4 in ethanol and heating at 110°C. The apolar and polar lipids were
prepared fromM. smegmatis cells according to the published procedures
(24). Apolar lipids were developed with chloroform-methanol (96:4;
three times) in the first dimension and toluene-acetone (80:20) in the
second dimension. Lipids were detected by charring with 5% phospho-
molybdic acid.
Proteomics. M. smegmatis control and Rv3852- and Rv3852CTD-
expressing cells were grown in 7H9mediumwith 2% acetamide at 37°C to
an OD600 of1.5. The cells were harvested, washed twice with PBS, and
resuspended in 2 ml of lysis buffer (10 mM HEPES, pH 8.0, 7% urea,
4% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propane-
sulfonate}, 2 M thiourea, 10 mM dithiothreitol [DTT]), followed by son-
ication. The lysate was cleared with a ReadyPrep 2-D Cleanup Kit (Bio-
Rad). Immobilized pH gradient strips, pH 4 to 7 (Bio-Rad; 17 cm), were
rehydrated with 300 g of total protein. Isoelectric focusing (IEF) was
carried out on a Protean i12 IEF Cell (Bio-Rad) using the following steps:
(i) 0 to 500 V linear for 2 h, (ii) 250 V rapid for 2 h, (iii) 250 to 6,000 V
linear for 3 h, and (iv) 6,000 V constant to 50 kVh. After equilibration, the
strips were loaded and resolved on 10% SDS-PAGE. The gels were stained
with a ProteoSilver Kit (Sigma-Aldrich), and the spots that differed in
intensity between the samples were identified by mass spectrometry.
RNA extraction and qPCR. RNAwas extracted from E. coli,M. smeg-
matis, andM. tuberculosis cells using aQiagen RNeasy kit according to the
manufacturer’s protocol. From the total RNA, cDNAs were synthesized
using a Fermentas first-strand synthesis kit. cDNA generated with ran-
domprimers was used for quantitative real-time PCR (qPCR), with SYBR
Mycobacterium tuberculosis Nucleoid-Associated Protein
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green as the indicator dye. The expression of the groEL1, kasA, and kasB
genes was quantified after normalization of RNA levels to the expression
of the rpoB genes, as previously described (19). The qPCR cycling condi-
tions were as follows: 95°C for 2 min, followed by 40 cycles of 95°C for 15
s, 58°C for 30 s, and 72°C for 20 s.
RESULTS AND DISCUSSION
Rv3852 does not complement an E. coli hns knockout strain.
From the sequence alignment ofE. coliH-NS andRv3852 depicted
in Fig. 1A, it is evident that the two proteins have little similarity;
although they are annotated as H-NS, only 12 residues are con-
served between them. Initially, to determine whether Rv3852
could functionally mimic H-NS and complement its deficiency in
an E. coli hns KO strain, the gene was cloned into the E. coli ex-
pression vector pBAD33 and transformed into an E. coli hns KO
strain. Western blot analysis using anti-Rv3852 antibody indi-
cated that the expression of the protein is 1.7-fold higher than
the endogenous level in M. tuberculosis (see Fig. S1A in the sup-
plemental material). Deficiency of H-NS in E. coli is associated
with several phenotypes, including mucoidy (25), glucoside utili-
zation (26), and hemolytic activity (27). The E. coli hns KO strain
harboring the pBAD33 vector alone or a plasmid expressing
Rv3852 remainedmucoid, while the strain complemented with E.
coli hns became nonmucoid and resembled the wild-type colonies
(Fig. 1B). Next, whether Rv3852 is functionally similar toH-NS in
the regulation of -glucoside metabolism was investigated. Genes
necessary for uptake and fermentation of aryl--D-glucosides are
included in the bgl operon, which is predominantly cryptic due to
its repression by H-NS (26). The fermentation of aryl--D-gluco-
sideswas examined onMacConkey agar plates supplementedwith
0.4% salicin. Thewild-typeE. coli strain, unable to ferment salicin,
grew as yellow colonies, and the hns KO strain appeared red, in-
dicating the fermentation of salicin. The hns KO strain harboring
Rv3852 also remained red, while the positive-control E. coli hns-
complemented strain gave rise to yellow colonies (Fig. 1C). Thus,
in spite of expression1.7-fold-higher than the endogenous level
in M. tuberculosis (see Fig. S1A in the supplemental material),
Rv3852 did not functionally complement the E. coli hns KO phe-
notypes. On the other hand, Lsr2, another nucleoid-associated
protein found inmycobacteria and considered yet another homo-
logue of H-NS, complements the E. coli hns KO phenotypes (9).
Further, Lsr2 has been shown to possess H-NS-like DNA binding
properties in vitro, indicating that there is a functional relatedness
between Lsr2 and H-NS (10).
Next, to study the biochemical properties of the protein, the
Rv3852 gene was cloned and expressed inM. smegmatis using the
pJAM2 inducible expression system (16). The ectopic expression
of the protein caused marginal reduction in the growth of M.
smegmatis cells (see Fig. S1A and B in the supplemental material).
The recombinant protein showed an anomalous mobility of21
kDa in 15% SDS-PAGE and was identified as Rv3852 by peptide
mass fingerprinting (data not shown). The purified protein
formed DNA-protein complexes upon incubation with 30-bp
double-stranded DNA substrate (Fig. 2A). The protein bound to
DNA in a sequence-independent manner, and with increasing
protein concentrations, the DNA-protein complexes were in-
creased. At higher concentrations (75 to 100 nM) of the protein,
the DNA-protein complexes failed to enter the gel, suggesting the
formation of higher-order oligomeric DNA-protein structures, as
reported previously (28). These structures presumably formed
due to the cooperative binding of the protein on DNA. Self-asso-
ciation, DNA-dependent oligomerization, and sequence-inde-
pendent DNA binding are the characteristic features of many
NAPs (29, 30). In addition to the DNA binding properties, the
abundance of the NAPs in the cells contributes to the compact
organization of the genome. Semiquantitative Western blotting
using ani-Rv3852 antibody (see Fig. S2 in the supplemental mate-
rial) indicated that the endogenous Rv3852 level inM. tuberculosis
H37Ra was 80,000 molecules/cell at exponential phase, a level
comparable to those of major NAPs of E. coli (14).
Alteration of nucleoidmorphology.When the nucleoidmor-
phology was examined using fluorescence microscopy, Rv3852-
expressing cells were of normal size and shape, but the DAPI-
stained nucleoids were more diffused and spread throughout the
cell than the control cells, which had compact nucleoids (Fig. 2B).
The decompaction of the nucleoid seen with the overproduction
of Rv3852 is in contrast to the overexpression of E. coliH-NS (31).
The NAPs are the key players in the organization and compaction
of bacterial chromosomes (32–34). Most of the NAPs alter the
trajectory of theDNAby bridging, bending, orwrapping it (32, 33,
35). Genome-wide studies in E. coli indicated that they are directly
involved in the formation ormaintenance of topological domains
in the chromosome, in addition to topoisomerases, which also
influence the nucleoid structure (5). The topological status of the
genome is maintained by the combined actions of DNA gyrase,
which catalyzes negative supercoiling, and topoisomerase I, which
FIG 2 Rv3852 binds to DNA and changes the nucleoid morphology. (A) The
DNA binding property of Rv3852 was analyzed by EMSA using 30 bp double-
stranded DNA (dsDNA). (B) Fluorescent micrographs of the DAPI-stained
nucleoid of M. smegmatis cells. (Left) Condensed nucleoid in control cells.
(Middle)Decompaction of nucleoid in Rv3852-expressing cells. (Right) Com-
pact nucleoid in Rv3852CTD-expressing cells. The cells shown are represen-
tative of 85% of the population. Bars, 1 M. DIC, differential interference
contrast.
Ghosh et al.
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relaxes DNA and prevents hypernegative supercoiling (36). Ge-
netic studies in E. coli showed that some of the NAPs, such as HU,
cross talk with topoisomerases and influence their function (37).
To examine whether Rv3852 has any influence on topoisomerase
I and DNA gyrase activities, coupled topoisomerase assays were
carried out as described in Materials and Methods. There was no
significant effect of Rv3852 on the supercoiling activity of gyrase
or on the DNA relaxation activity of topoisomerase I (see Fig. S3A
and B in the supplemental material), indicating that the change in
nucleoid morphology seen with the protein is most likely due to
the direct DNA-protein interaction and not to any effect through
topoisomerases.
Ultrastructure analysis. To investigate the finer details of the
nucleoid organization, ultrastructure analysis was carried out us-
ing transmission electron microscopy. The electron micrograph
of Rv3852-expressing cells showed an altered nucleoid structure,
characterized by less condensed and decompacted nucleoid (Fig.
3B and C), compared to that of control cells (Fig. 3A). These
results correlated well with fluorescence microscopic studies. In
addition to the difference in nucleoidmorphology, unusualmem-
brane structures were also observed in Rv3852-expressing cells
(Fig. 3C). Higher-magnification imaging revealed the presence of
spiral membrane invaginations in the cytoplasm of the cells
(Fig. 3D) resembling membrane structures associated with the
overproduction of the b subunit of F1Fo ATP synthase (38) or
chemotaxis receptor Tsr protein (39) in E. coli. In this context, it is
noteworthy that electron tomography analysis had demonstrated
that the overproduction of integral membrane proteins led to the
formation of large membrane networks that extended into the
cytoplasm as zippered and rounded assemblies, probably to ac-
commodate large amounts of membrane proteins within a de-
fined space (39). There are also examples of naturally occurring
membrane clusters in certain cyanobacteria (40). The formation
of the extended membrane structures in Rv3852-overexpressing
cells thus indicated that the protein may be associated with the
membrane.
Rv3852 has a transmembrane helix. To investigate the possi-
bility that Rv3852 is indeed a membrane-bound protein, first, a
detailed bioinformatics analysis was carried out. The multiple-
sequence alignment of Rv3852 homologues among the patho-
genic mycobacterial species showed a highly conserved sequence
at the C-terminal end (see Fig. S4A in the supplemental material),
and the hydropathy index analysis revealed it to be hydrophobic
(see Fig. S4B in the supplemental material). The TMHMM and
TMpred tools predicted a transmembrane helix spanning from
111 to 132 amino acids (see Fig. S5A and B in the supplemental
material). Analysis of the predicted helix by a helical-wheel algo-
rithm indicated the helical arrangement of the hydrophobic
amino acids in the helix (see Fig. S5C and D in the supplemental
material). The subcellular fractionation of cells expressing Rv3852
and Western blot analysis with anti-Rv3852 antibody demon-
strated the localization of the protein in the membrane fraction
(Fig. 4A). To investigate further the role of the predicted C-termi-
nal transmembrane helix in membrane localization, a truncated
Rv3852 construct (Rv3852CTD) that lacked the C-terminal 24
amino acids was generated. Unlike the full-length protein, the
truncated protein was retained predominantly in a cytosolic frac-
tion (Fig. 4A), suggesting that the C-terminal helix is responsible
for membrane localization of the protein. To analyze the localiza-
tion of endogenous Rv3852 inM. tuberculosisH37Ra cells, immu-
FIG 3 Ultrastructure analysis of Rv3852-expressingM. smegmatis cells. (A and B) The compact nucleoid regions of control cells are indicated by arrows (A), and
the decompacted nucleoid of an Rv3852-expressing cell is indicated by an arrow and bracket (B). (C) Cells expressing Rv3852 showing the presence of a spiral
membrane structure (boxed). (D) Higher-magnification image of the spiral structure.
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noelectron microscopy was carried out with anti-Rv3852 poly-
clonal antibody. Similar to the above observations, the proteinwas
found localized in the membrane (Fig. 4B). A recent study on the
membrane proteomeofM. tuberculosis also showed that Rv3852 is
present in the membrane (41). Thus, in addition to its role in
nucleoid organization, Rv3852 may function as an anchorage to
tether the DNA to the membrane. To test whether Rv3852 indeed
has the DNA anchorage property, the DNA was isolated from
membrane fractions of Rv3852- and Rv3852CTD-expressing
cells, as well as from control cells. The 3-fold increase of the
DNA content in the membrane fraction of Rv3852-expressing
cells compared to the control and Rv3852CTD cells (Table 1)
indicated that Rv3852 can tether DNA to the membrane. To fur-
ther assess the contribution of Rv3852 in anchoring DNA to the
membrane, the nucleoid morphology of the cells expressing the
Rv3852CTD protein was analyzed. Unlike the full-length pro-
tein, the nucleoids of Rv3852CTD-expressing cells appeared
compact (Fig. 2B, right). Thus, Rv3852 could be decompacting the
nucleoid by tethering DNA to the membrane.
Phenotypic changes: pellicle and biofilm formation, colony
morphology, and slidingmotility. To understand the physiolog-
ical role of Rv3852, the phenotypic changes associated with the
ectopic expression of the protein inM. smegmatiswere examined.
Cells showed increased clumping (data not shown) upon expres-
sion of the protein. The strain expressing Rv3852 showed wrin-
kled, rough, and dry colonies with an uneven colony surface in
contrast to control colonies with more even edges (Fig. 5A). De-
fects in cell wall components can modify the surface properties of
the individual cells, alter cell-to-cell interactions, and give rise to
colonies with visibly different morphologies (42). Mycobacteria
grown in the absence of detergent form a surface pellicle in stand-
ing liquid media, and this property is attributed to the high lipid
content of the cells (43). However, in contrast to the control cells,
which formed pellicles, pellicles were not detected in the Rv3852-
expressing cells (Fig. 5B). Pellicle growth and the formation of
biofilm are well correlated in different bacterial species (44, 45).
Biofilms are considered to be surface-associated bacterial commu-
nities comprising microcolonies surrounded by extracellular ma-
trix (46). Mycobacteria form biofilms either attached to hydro-
phobic solid surfaces or floating as pellicles on the surfaces of
liquid culturemedia. Therefore, the ability of the Rv3852-express-
ing strain to form biofilms on PVC plastic surfaces was tested
using an M63-based liquid medium. Biofilm formation was sig-
nificantly reduced in the strain compared to that of the control
cells (Fig. 5C). Quantification by crystal violet staining assay re-
vealed an5-fold reduction in the biofilm upon Rv3852 expres-
sion (data not shown).
Biofilm formation and sliding motility are well correlated in
mycobacteria (47). The members of the genus Mycobacterium
were originally considered to be nonmotile until sliding motil-
ity in M. smegmatis and Mycobacterium avium was demon-
strated on solid surfaces (23). As with biofilm formation, the
sliding motility of the Rv3852-expressing strain on a motility
plate showed an altered phenotype. The diameter of the sliding
halo showed 4-fold reduction in size (Fig. 5D), indicating
reduced sliding motility.
To investigate whether the changes in surface phenotypes were
due to the membrane localization of Rv3852, the truncated pro-
tein, Rv3852CTD, which exhibited cytosolic localization
(Fig. 4A), was expressed in M. smegmatis and tested for the phe-
notypic changes. The expression of the truncated protein in M.
smegmatis cells showed phenotypes similar to that of expression of
the full-length protein (Fig. 5). These data indicated that the
change in surface properttes is not solely correlatedwith themem-
brane localization, and there may be a regulatory role for Rv3852
in modulation of biofilm formation and different surface pheno-
types. Several key regulatory proteins of biofilm formation have
been identified in different bacteria. It has been shown that CsrA
(a carbon storage regulator), an RNA-binding protein, and Fis, a
NAP, act as regulators of biofilm formation in E. coli and Dickeya
dadantii, respectively (48, 49). Overexpression of a diguanylate
cyclase or phosphodiesterase resulted in modulating the intracel-
lular cyclic di-GMP (c-di-GMP) pool and consequently induced
the dispersion of Shewanella oneidensis biofilms (50). A relation-
ship between a defect in biofilm formation and inability to slide
has been shown in M. smegmatis GPL biosynthesis gene (atf1)
mutants (51). Biofilm formation in M. smegmatis is associated
with changes in the profile of mycolic acids in the mycobacterial
cell wall, and GroEL1, a dedicated chaperone, has been shown to
play a regulatory role in this process (52). Lsr2 has also been
shown to be a regulator of mycobacterial biofilm formation; cells
TABLE 1 DNA contents of membrane fractions derived from different
M. smegmatis strains
M. smegmatis strain
DNA content (ng/20 g of
membrane protein)a
Control 3.02 0.15
Rv3852 9.84 0.22
Rv3852CTD 3.68 0.11
a Mean standard deviation; n 3.
FIG 4 Rv3852 is localized in the cell membrane. (A) Subcellular fractionation of
Rv3852-containing cells indicating the presence of the protein inmembrane frac-
tions. Truncated Rv3852 lacking the transmembrane helix (Rv3852CTD) local-
izes in the cytosolic fraction. (B) Immunogold stainingofM. tuberculosis cellswith
anti-Rv3852 antibody. The gold particles (arrow) indicate the presence of Rv3852
in the membrane.
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lacking Lsr2 were unable to form biofilm (12). In contrast to these
observations, expression of Rv3852 affected biofilm formation.
Thus, it appears that the regulatory role of Rv3852 in biofilm for-
mation is different from and opposite to that of Lsr2.
Cell wall lipid analysis. The changes in colony morphology
and biofilm formation suggested that Rv3852 expression affected
some component of the mycobacterial cell wall. Since the muta-
tion in the GPL biosynthetic pathway affects biofilm formation
(51), we first tested whether the GPL composition was changed
due to Rv3852 expression. GPLs extracted from the strains were
analyzed byTLC. TheRv3852- andRv3852CTD-expressing cells
exhibited normal GPLs with no detectable change in the profile
(data not shown), and hence, we examined the profiles of other
cell wall lipids. TLC analysis of polar lipids also did not reveal any
differences (data not shown), but apolar lipids had distinct TLC
profiles. Two lipid spots present in Rv3852- and truncated-pro-
tein-expressing cells (Fig. 6A) were detected in relatively small
amounts in the control cells, indicating that the protein alters the
cell wall lipid composition by modulating the lipid biosynthesis
pathway. Contributions by lipids, in addition to outer membrane
proteins and extracellular polysaccharides, in biofilm matrix for-
mation have been reported previously (46, 52, 53). The alteration
in the extracellular-matrix content can probably explain both the
reduced sliding motility and the defective biofilm formation ob-
served in cells expressing Rv3852.
All the results described so far indicate that Rv3852 differs from
E. coli H-NS in its properties, whether it is the primary sequence,
the role in nucleoid organization, or the phenotypic characteris-
tics. On the other hand Lsr2 ofM. tuberculosis, although structur-
ally distinct, exhibited characteristics similar to those of E. coli
H-NS (9). Hence, we suggest that Rv3852 could be renamed my-
cobacterialDNAbinding protein 2 (MDP2), sinceHU (Rv2986c),
another mycobacterial nucleoid-associated protein, is already
named MDP1 (54).
MDP2 regulates the expression of lipid biosynthetic genes.
To analyze the effect of MDP2 expression on the total proteome,
two-dimensional (2D) PAGE analysis was carried out as described
in Materials and Methods. The comparative profiling of control
cells versus cells expressing MDP2 or the truncated protein re-
sulted in identification of two unique spots that show reduction
upon expression of the proteins (Fig. 6B to D). Peptide mass fin-
gerprinting analysis identified the spots as GroEL1 chaperone and
FIG 5 Phenotypic changes ofM. smegmatis cells. The Rv3852- and Rv3852CTD-expressing cells show altered colonymorphology (A), reduced pellicle (B) and
biofilm formation (C), and decreased sliding motility (D) compared to control cells.
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KasA. GroEL1 is a dedicated chaperone involved in heat shock
response inmycobacteria. The lack of GroEL1 results in reduction
in biofilm maturation and accumulation of free mycolic acids in
M. smegmatis cells (52). GroEL is also known to stabilize the KasA
protein, a key component of the mycolic acid biosynthetic path-
way (52). Biosynthesis of mycolic acid requires two types of fatty
acid synthase (FAS), FAS I, a multifunctional enzyme capable of
de novo synthesis of medium-chain fatty acids, and the ACP-de-
pendent FAS II system, responsible for their elongation (55). The
FAS II pathway is composed of two main transcriptional units,
fabD-acpM-kasA-kasB-accD6 (the fasII operon) and mabA-inhA
(15). The KasA andKasB proteins expressed from the fasII operon
are involved in elongation of mycolic acid chains (55) and defi-
ciency or reduction in their levels is associated with reduction in
biofilm formation (52), altered colony morphology (56), and ac-
cumulation of precursors ofmycolic acid biosynthesis (55, 56). To
investigate the regulatory role of MDP2 in the expression of these
genes, the transcript level was estimated by qPCR. The steady-
state groEL1mRNA level was reduced by3-fold, while kasA and
kasB expression was downregulated by 3.5- and 2-fold, re-
spectively, in MDP2- and truncated-protein-expressing cells
compared to control cells (Fig. 6E). The repression of groEL1 and
the fasII operon genes seen when MDP2 was expressed indicated
that the protein might be acting as a negative regulator of their
transcription.
In conclusion,MDP2 is a distinctNAP, different in all its prop-
FIG 6 Effect of Rv3852 expression on theM. smegmatis lipid profile and proteome. (A) 2D-TLC profile of apolar lipids developed with chloroform-methanol
(96:4; three times) in the first dimension and toluene-acetone (80:20) in the second dimension. The arrow indicates the lipid spots, which are more intense in
Rv3852- and Rv3852CTD-expressing cells. (B to D) Analysis of the total proteome profile ofM. smegmatis cells. The boxes indicate the protein species present
at reduced levels in theRv3852- and truncated-protein-expressing cells relative to the control. (E) Relative expression profile of groEL1, kasA, and kasB in Rv3852-
and Rv3852CTD-expressing cells as determined by qPCR. The cycle threshold (CT) value of each gene was normalized with the housekeeping gene rpoB. The
error bars indicate standard deviations.
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erties from E. coli H-NS and M. tuberculosis Lsr2. The protein
apparently binds to DNA in a nonspecific fashion and alters nu-
cleoid compaction. Unlike the action of Lsr2, its expression leads
to reduced biofilm formation and sliding motility and a change in
colony morphology. These changes could be attributed to altera-
tion in the lipid profile due to transcriptional downregulation of
groEL1 and fasII operon genes by MDP2, suggesting a major role
for the protein in regulation of lipid biosynthesis inmycobacteria.
Thus, it appears that in M. tuberculosis each of the NAPs charac-
terized (MDP1, MDP2, and Lsr2) has a designated physiological
role important to the cellular function. Such designated roles may
be necessary when there is an underrepresentation of NAPs in the
genome.
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